See the full story in the original article.
Read the original on MarketWatch ↗
Keywords
Medicarehealthcarepharmaceuticalsretirees
Open a keyword to see other news on the same topic.
Related news
- A new Medicare season begins , but some shifts will arrive in 2027
- A new Medicare season begins , but some shifts will arrive in 2027
- A new Medicare season begins , but some shifts will arrive in 2027
Medicare open enrollment begins Thursday and runs through Dec. 7, letting people choose between traditional Medicare, Medicare Advantage plans and prescription drug plans, with changes taking effect Jan. 1, 2027. The Part D out-of-pocket cap will rise to $2,400 from $2,100 in 2026, the standard deductible will increase from $615 to $700, and the temporary Part D premium subsidy will end early. New Medicare-negotiated prices will take effect for 15 drugs, including Ozempic, Rybelsus and Wegovy. President Donald Trump has also promised one-time $90 payments in October to more than 20 million Medicare enrollees to help with Part B premiums, at a cost of about $2 billion.
- A new Medicare season begins , but some shifts will arrive in 2027
Open enrollment for Medicare plans begins Thursday and runs until Dec. 7, letting enrollees choose between traditional Medicare, Medicare Advantage plans and prescription drug plans, with changes taking effect Jan. 1, 2027. The Part D out-of-pocket cap will rise to $2,400 from $2,100, the standard deductible will increase to $700 from $615, and a temporary federal Part D premium subsidy will end at year's end. New Medicare-negotiated prices for 15 drugs, including Ozempic, Rybelsus and Wegovy, will take effect, and CMS expects this to lower prescription drug coverage by $685 million in 2027. Separately, Social Security benefits will rise 3.6% in 2027, about $75 more per month, while President Trump said one-time $90 payments will go to more than 20 million Medicare enrollees in October.
- Medicare open enrollment : Why premiums could increase for some enrollees
Medicare open enrollment runs from Oct. 15 to Dec. 7, with changes taking effect Jan. 1. The annual out-of-pocket cap for Part D drugs rises to $2,400 from $2,100 in 2026, the standard deductible increases from $615 to $700, and the Trump administration is ending a temporary Part D premium subsidy. According to KFF, enrollees in United AARP-branded Part D plans who don't change plans will see monthly premiums rise by $50 or more in all 50 states, and by more than $75 in 37 states. Fifteen drugs, including Ozempic, Rybelsus and Wegovy, will get Medicare-negotiated prices, and the Centers for Medicare and Medicaid expects the change to reduce prescription drug coverage costs for enrollees by $685 million in 2027. KFF notes many enrollees don't compare plans during open enrollment, even though cheaper options exist.
- Medicare Open Enrollment Begins, 2027 Plan Changes Announced
Medicare open enrollment runs from October 15 to December 7 for coverage effective January 1, 2027, affecting more than 70 million enrollees. Beneficiaries can choose traditional Medicare, private Medicare Advantage plans, or prescription drug plans. The Social Security Administration says benefits will rise 3.6% in 2027, about $75 more per month for nearly 72 million recipients. The Part D out-of-pocket cap rises from $2,100 in 2026 to $2,400 in 2027, the standard deductible increases from $615 to $700, and a temporary Part D premium subsidy will end early at year's end. Negotiated prices for 15 drugs take effect January 1, and CMS projects a $685 million impact on Medicare prescription drug coverage in 2027.
Related markets
Latest news
- Gold surges on evening of Nov 4 after US election results
Gold prices rose nearly 3% in the Nov 4 session to above 4,040 USD/ounce as the US dollar weakened after Democrats' decisive win in the US midterm elections. At 10 p.m. Vietnam time, spot gold was up 2.7% at 4,036 USD/ounce, heading for its biggest daily gain since August 19. Hamad Hussain of Capital Economics said the Democratic victory appears to be lifting gold as investors grow more worried about the US fiscal outlook. Democrats won control of both the Senate and House, a result that reflects strong voter backlash against President Donald Trump. Investors are also watching US jobs data for clues on the Federal Reserve's interest rate path, a factor that significantly affects gold prices.
- Micron and other chip stocks slip as election results strike at the core of data-center optimism
Micron and other chip stocks slipped as election results came in. Democratic wins in Texas and other states raise long-term questions about the AI buildout, though the article notes these results do not 'unwind projects already funded'.
- Better AI Semiconductor Monopoly Stock: Taiwan Semiconductor vs. ASML
The semiconductor industry generated $792 billion in revenue in 2025, up nearly 26% from 2024, and McKinsey estimates it could reach $2.3 trillion in 2030, above the $1.6 trillion guidance issued a year ago. ASML's sales of new lithography systems rose 71% year over year to 113 units last quarter, and its Q3 revenue increased 55% to 11.66 billion euros, with plans to raise EUV capacity by 30% next year. TSMC's Q3 revenue grew 41% year over year to $46.7 billion, and it holds 73% of the global foundry market according to Counterpoint Research, with 79% of its revenue from chips at 7nm or below. The article notes that ASML is growing faster but carries a premium valuation, while TSMC is presented as a mix of growth and value.
- SpaceX and Tesla 'need to find the path forward with Texas' on the back of midterm 'Blue Wave'
Tesla (TSLA) and SpaceX (SPCX) shares fell over 2% on Wednesday despite a broad market rally, after Democrats took control of both houses of Congress in a 'Blue Wave' that flipped Texas, home to both companies. Musk spent $224 million backing Texas Republicans, part of at least $446 million he gave to Republican candidates and groups before the vote. Democrat Gina Hinojosa unseated Gov. Greg Abbott to become the first Democratic governor of Texas since 1990, and she has pledged a moratorium on new data center construction in the state, a move that threatens the AI buildout underpinning both stocks. Reports suggest a push to announce a Tesla-SpaceX merger by the first half of 2027, though talks remain exploratory. Wedbush's Dan Ives wrote that Musk 'needs to find the path forward with Texas' after the Democratic wins.
- Qualcomm sat out the semiconductor rally. Can a SpaceX partnership change that?
Qualcomm is expanding beyond the handset market, with its technology powering Starlink Mobile. The article gives no further financial figures or timeline for the project.
- How Could Cadence Design Systems (CDNS) New AI Push Expand Its Market?
Cadence Design Systems (CDNS) introduced its Maestro AI Model Portfolio, a suite of AI agents for chip and system design workflows, and announced a collaboration with NVIDIA on agent security within these design environments. It also opened a sovereign AI data center in Munich to provide Europe-based infrastructure for AI and electronic design workloads. The article says these moves reinforce rather than rewrite Cadence's existing narrative, and points to adoption of agentic AI products in reported numbers and 2027 guidance as the clearest signal to watch.
Get the briefing on Telegram or Zalo
Join the Upside Telegram channel or Zalo group for the Vietnam stocks and gold briefing at 8:00 and 19:00 (Vietnam time) on trading days, plus a weekly wrap on Saturday morning.